Nuclear Receptor NR4A2 Orchestrates Th17 Cell-Mediated Autoimmune Inflammation via IL-21 Signalling

M Sospedra, 2005, Immunology of multiple sclerosis, Annu Rev Immunol, 23, 683, 10.1146/annurev.immunol.23.021704.115707

E Bettelli, 2007, Th17: the third member of the effector T cell trilogy, Curr Opin Immunol, 19, 652, 10.1016/j.coi.2007.07.020

JM Damsker, 2010, Th1 and Th17 cells: adversaries and collaborators, Ann N Y Acad Sci, 1183, 211, 10.1111/j.1749-6632.2009.05133.x

T Korn, 2007, Th17 cells: effector T cells with inflammatory properties, Semin Immunol, 19, 362, 10.1016/j.smim.2007.10.007

J Goverman, 2009, Autoimmune T cell responses in the central nervous system, Nat Rev Immunol, 9, 393, 10.1038/nri2550

A Jager, 2009, Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes, J Immunol, 183, 7169, 10.4049/jimmunol.0901906

D Luger, 2008, Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category, J Exp Med, 205, 799, 10.1084/jem.20071258

L Steinman, 2008, A rush to judgment on Th17, J Exp Med, 205, 1517, 10.1084/jem.20072066

S Man, 2007, Inflammatory cell migration into the central nervous system: a few new twists on an old tale, Brain Pathol, 17, 243, 10.1111/j.1750-3639.2007.00067.x

D Matusevicius, 1999, Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis, Mult Scler, 5, 101, 10.1177/135245859900500206

K Hirota, 2011, Fate mapping of IL-17-producing T cells in inflammatory responses, Nat Immunol, 12, 255, 10.1038/ni.1993

E Bettelli, 2006, Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells, Nature, 441, 235, 10.1038/nature04753

T Korn, 2009, IL-17 and Th17 Cells, Annu Rev Immunol, 27, 485, 10.1146/annurev.immunol.021908.132710

T Korn, 2007, IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells, Nature, 448, 484, 10.1038/nature05970

J Das, 2009, Transforming growth factor beta is dispensable for the molecular orchestration of Th17 cell differentiation, J Exp Med, 206, 2407, 10.1084/jem.20082286

K Ghoreschi, 2011, Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling, Nature, 467, 967, 10.1038/nature09447

DJ Cua, 2003, Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain, Nature, 421, 744, 10.1038/nature01355

MJ McGeachy, 2007, The link between IL-23 and Th17 cell-mediated immune pathologies, Semin Immunol, 19, 372, 10.1016/j.smim.2007.10.012

SW Law, 1992, Identification of a new brain-specific transcription factor, NURR1, Mol Endocrinol, 6, 2129

T Perlmann, 2004, Nurr1, an orphan nuclear receptor with essential functions in developing dopamine cells, Cell Tissue Res, 318, 45, 10.1007/s00441-004-0974-7

WD Le, 2003, Mutations in NR4A2 associated with familial Parkinson disease, Nat Genet, 33, 85, 10.1038/ng1066

MA Pearen, 2010, Minireview: Nuclear Hormone Receptor 4A Signaling: Implications for Metabolic Disease, Mol Endocrinol, 24, 1, 10.1210/me.2010-0015

CM Aherne, 2009, Identification of NR4A2 as a transcriptional activator of IL-8 expression in human inflammatory arthritis, Mol Immunol, 46, 3345, 10.1016/j.molimm.2009.07.019

M O'Kane, 2008, Increased expression of the orphan nuclear receptor NURR1 in psoriasis and modulation following TNF-alpha inhibition, J Invest Dermatol, 128, 300, 10.1038/sj.jid.5701023

K Saijo, 2009, A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death, Cell, 137, 47, 10.1016/j.cell.2009.01.038

J Satoh, 2005, Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis, Neurobiol Dis, 18, 537, 10.1016/j.nbd.2004.10.007

Y Doi, 2008, Orphan nuclear receptor NR4A2 expressed in T cells from multiple sclerosis mediates production of inflammatory cytokines, Proc Natl Acad Sci U S A, 105, 8381, 10.1073/pnas.0803454105

C Klemann, 2009, Synthetic retinoid AM80 inhibits Th17 cells and ameliorates experimental autoimmune encephalomyelitis, Am J Pathol, 174, 2234, 10.2353/ajpath.2009.081084

BJ Raveney, 2008, Fingolimod (FTY720) as an acute rescue therapy for intraocular inflammatory disease, Arch Ophthalmol, 126, 1390, 10.1001/archopht.126.10.1390

DA Copland, 2008, The clinical time-course of experimental autoimmune uveoretinitis using topical endoscopic fundal imaging with histologic and cellular infiltrate correlation, Invest Ophthalmol Vis Sci, 49, 5458, 10.1167/iovs.08-2348

EP Mensah-Brown, 2006, IL-23 leads to diabetes induction after subdiabetogenic treatment with multiple low doses of streptozotocin, Eur J Immunol, 36, 216, 10.1002/eji.200535325

JM Fraser, 2006, Abortive activation precedes functional deletion of CD8+ T cells following encounter with self-antigens expressed by resting B cells in vivo, Immunology, 119, 126, 10.1111/j.1365-2567.2006.02414.x

BJ Raveney, 2009, TNFR1-dependent regulation of myeloid cell function in experimental autoimmune uveoretinitis, J Immunol, 183, 2321, 10.4049/jimmunol.0901340

H Shao, 2006, Severe chronic experimental autoimmune uveitis (EAU) of the C57BL/6 mouse induced by adoptive transfer of IRBP1–20-specific T cells, Exp Eye Res, 82, 323, 10.1016/j.exer.2005.07.008

D Elias, 1994, Autoimmune diabetes induced by the beta-cell toxin STZ. Immunity to the 60-kDa heat shock protein and to insulin, Diabetes, 43, 992, 10.2337/diab.43.8.992

L Zhou, 2008, TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function, Nature, 453, 236, 10.1038/nature06878

T Sekiya, 2011, The nuclear orphan receptor Nr4a2 induces Foxp3 and regulates differentiation of CD4+ T cells, Nat Commun, 2, 269, 10.1038/ncomms1272

L Zhou, 2007, IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways, Nat Immunol, 8, 967, 10.1038/ni1488

R Nurieva, 2007, Essential autocrine regulation by IL-21 in the generation of inflammatory T cells, Nature, 448, 480, 10.1038/nature05969

L Ivanov, II, Zhou, 2007, Transcriptional regulation of Th17 cell differentiation, Semin Immunol, 19, 409, 10.1016/j.smim.2007.10.011

AT Bauquet, 2009, The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells, Nat Immunol, 10, 167, 10.1038/ni.1690

M Veldhoen, 2008, The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins, Nature, 453, 106, 10.1038/nature06881

F Takeshita, 2005, Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo, Proc Natl Acad Sci U S A, 102, 12177, 10.1073/pnas.0501753102

W Hueber, 2011, Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis, Sci Transl Med, 2, 52ra72

HH Hofstetter, 2005, Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis, Cell Immunol, 237, 123, 10.1016/j.cellimm.2005.11.002

Y Komiyama, 2006, IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis, J Immunol, 177, 566, 10.4049/jimmunol.177.1.566

G Monteleone, 2005, Interleukin-21 enhances T-helper cell type I signaling and interferon-gamma production in Crohn's disease, Gastroenterology, 128, 687, 10.1053/j.gastro.2004.12.042

CL Langrish, 2005, IL-23 drives a pathogenic T cell population that induces autoimmune inflammation, J Exp Med, 201, 233, 10.1084/jem.20041257

WJ Leonard, 2005, Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation, Nat Rev Immunol, 5, 688, 10.1038/nri1688

TL Vollmer, 2005, Differential effects of IL-21 during initiation and progression of autoimmunity against neuroantigen, J Immunol, 174, 2696, 10.4049/jimmunol.174.5.2696

JM Coquet, 2008, Cutting edge: IL-21 is not essential for Th17 differentiation or experimental autoimmune encephalomyelitis, J Immunol, 180, 7097, 10.4049/jimmunol.180.11.7097

I Sonderegger, 2008, IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo, Eur J Immunol, 38, 1833, 10.1002/eji.200838511